Profile data is unavailable for this security.
About the company
Tanvex BioPharma, Inc. is a Cayman Islands-based biopharmaceutical company focused on the biosimilar market. The company has expertise in areas, including strain and cell-line development in both microbial and mammalian systems, cell culture, protein purification, process scale-up, drug substance and product manufacturing, and others. The Company’s product pipeline includes Neupogen (TX-01), Herceptin (TX-05), Neulasta (TX-04), Avastin (TX-16), Perjeta (TX-52), and others. The Company offers a vertically integrated manufacturing platform for biopharmaceuticals. The Company is developing and delivering biologic and biosimilar drugs to people.
- Revenue in TWD (TTM)34.56m
- Net income in TWD-1.81bn
- Incorporated2013
- Employees--
- LocationTanvex BioPharma IncFloor 4, Willow House, Cricket Square,P O BOX 2804GRAND CAYMAN KY1-1112Cayman IslandsCYM
- Websitehttp://www.tanvex.com/
More ▼